Ignite Creation Date:
2024-05-05 @ 11:02 PM
Last Modification Date:
2024-10-26 @ 10:27 AM
Study NCT ID:
NCT01241214
Status:
COMPLETED
Last Update Posted:
2019-05-15
First Post:
2010-11-12
Brief Title:
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
Sponsor:
Idorsia Pharmaceuticals Ltd
Organization:
Idorsia Pharmaceuticals Ltd
Study Overview
Official Title:
A Multi-center Double-blind Randomized Placebo-controlled Active Reference Parallel-group Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
Status:
COMPLETED
Status Verified Date:
2019-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SAR
Brief Summary:
This study will assess the efficacy and safety of different doses of ACT-129968 in adult patients with seasonal allergic rhinitis due to mountain cedar pollen
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None